Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzon Pharmaceuticals Inc (OTCQX US:ENZN)

0.449
Delayed Data
As of 3:58pm ET
 +0.014 / +3.22%
Today’s Change
0.35
Today|||52-Week Range
0.73
-34.21%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$19.2M

Company Description

Enzon Pharmaceuticals, Inc. operates as a biopharmaceutical company. It receives royalty revenues from existing licensing agreements with other companies primarily related to sales of four marketed drug products namely PegIntron, Sylatron, Macugen, and CIMZIA. The company was founded by Abraham Abuchowski on September 17, 1981 and is headquartered in Cranford, NJ.

Contact Information

Enzon Pharmaceuticals, Inc.
20 Commerce Drive
Cranford New Jersey 07016
P:(732) 980-4500
Investor Relations:

Employees

Shareholders

Individual stakeholders24.93%
Other institutional13.43%
Mutual fund holders1.87%

Top Executives

Andrew D. RackearChief Executive Officer & Secretary
Richard L. FeinsteinPrincipal Financial & Accounting Officer